First Light Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

First Light Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-72,443	Closed	-$5.05M	–	64
2020 Q2	$5.05M	Buy	72,443 +534	+0.7%	+$33.9K	0.59%	39
2020 Q1	$3.26M	Buy	71,909 +2,206	+3%	+$125K	0.56%	37
2019 Q4	$4.54M	Sell	69,703 -9,771	-12%	-$653K	0.58%	38
2019 Q3	$4.93M	Sell	79,474 -78,660	-50%	-$4.94M	0.75%	34
2019 Q2	$11.3M	Sell	158,134 -52,755	-25%	-$3.89M	1.56%	26
2019 Q1	$16.5M	Buy	210,889 +59,595	+39%	+$4.52M	2.15%	19
2018 Q4	$12.8M	Buy	151,294 +34,243	+29%	+$3.65M	2.04%	21
2018 Q3	$20M	Sell	117,051 -79,257	-40%	-$11.9M	3.23%	13
2018 Q2	$25.4M	Buy	196,308 +9,065	+5%	+$1.01M	3.95%	10
2018 Q1	$19.3M	Buy	187,243 +7,753	+4%	+$767K	4.24%	10
2017 Q4	$15.3M	Buy	179,490 +77,946	+77%	+$6.76M	4.2%	7
2017 Q3	$8.63M	Buy	101,544 +1,159	+1%	+$91.8K	2.73%	13
2017 Q2	$7.6M	Sell	100,385 -27	-0%	-$1.89K	2.55%	14
2017 Q1	$6.63M	Buy	100,412 +34,384	+52%	+$2.26M	2.53%	15
2016 Q4	$4.18M	Buy	66,028 +21	+0%	+$1.32K	1.84%	22
2016 Q3	$4.2M	Sell	66,007 -1,511	-2%	-$111K	1.81%	25
2016 Q2	$5.02M	Sell	67,518 -23,390	-26%	-$1.74M	2.33%	17
2016 Q1	$6.07M	Sell	90,908 -171	-0.2%	-$10.4K	3.06%	10
2015 Q4	$6.16M	Sell	91,079 -1,207	-1%	-$74.5K	2.58%	11
2015 Q3	$4.93M	Buy	92,286 +13,555	+17%	+$822K	2.44%	14
2015 Q2	$4.96M	Sell	78,731 -67,758	-46%	-$3.7M	2.33%	17
2015 Q1	$7.05M	Buy	146,489 +15,120	+12%	+$579K	3.6%	8
2014 Q4	$4.36M	Buy	131,369 +8,954	+7%	+$291K	2.47%	11
2014 Q3	$3.59M	Buy	122,415 +3,211	+3%	+$107K	2.45%	12
2014 Q2	$4.63M	Buy	119,204 +6,734	+6%	+$273K	3.12%	9
2014 Q1	$4.72M	Buy	112,470 +15,902	+16%	+$663K	3.34%	6
2013 Q4	$3.17M	Buy	+96,568	New	+$3.15M	2.69%	14

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

First Light Asset Management's LGND Position: Q3 2020 in Review

First Light Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2020, closing a stake of 72,443 shares — an estimated $5.05M sold.

First Light Asset Management first reported a position in LGND in Q4 2013 and held it in 27 quarters. The position peaked at $25.4M in Q2 2018. 252 funds tracked by Wall St. Rank hold LGND as of Q3 2020.

First Light Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
First Light Asset Management sold 72,443 Ligand Pharmaceuticals shares in Q3 2020, an estimated $5.05M.
First Light Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2013 and held it in 27 quarters.
First Light Asset Management's Ligand Pharmaceuticals position peaked at $25.4M in Q2 2018.
252 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2020.

Based on First Light Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.